INmune Bio, Inc.
INMB
$7.32
$0.010.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.64% | 7.99% | 19.49% | -27.47% | -14.27% |
| Total Receivables | -0.77% | -58.39% | 26.88% | 10.16% | 7.91% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -62.34% | -13.23% | -10.51% | -31.48% | 7.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -36.79% | 1.00% | 19.01% | -25.33% | -12.43% |
|
|
|||||
| Total Current Assets | -36.79% | 1.00% | 19.01% | -25.33% | -12.43% |
| Net Property, Plant & Equipment | -8.36% | -7.71% | -6.68% | -6.04% | -6.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.66% | 1.23% | -23.58% | -19.08% | 1.55% |
| Total Assets | -25.05% | 0.63% | 12.00% | -17.84% | -9.09% |
|
|
|||||
| Total Accounts Payable | -38.25% | 14.09% | -0.13% | 17.63% | 114.99% |
| Total Accrued Expenses | -54.55% | -60.43% | 148.21% | 60.00% | -55.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -94.67% | -48.54% | -32.60% | -24.50% | -0.65% |
| Total Finance Division Other Current Liabilities | -5.83% | 5.37% | 0.19% | 6.34% | -1.41% |
| Total Other Current Liabilities | -5.83% | 5.37% | 0.19% | 6.34% | -1.41% |
| Total Current Liabilities | -47.76% | -8.16% | -13.75% | -5.50% | 28.62% |
|
|
|||||
| Total Current Liabilities | -47.76% | -8.16% | -13.75% | -5.50% | 28.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.08% | -11.80% | -10.56% | -9.32% | -7.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -47.08% | -8.24% | -13.68% | -5.58% | 4.99% |
|
|
|||||
| Common Stock & APIC | 1.13% | 8.28% | 11.09% | 1.12% | 1.19% |
| Retained Earnings | -5.99% | -8.53% | -7.38% | -9.11% | -7.47% |
| Treasury Stock & Other | 44.50% | -45.30% | -6.58% | 16.27% | -8.71% |
| Total Common Equity | -17.01% | 6.60% | 28.55% | -24.41% | -15.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | 0.00% | 0.00% | 0.00% |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -17.01% | 6.60% | 28.55% | -24.41% | -15.01% |
| Total Preferred Equity | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.01% | 4.30% | 27.76% | -23.90% | -14.74% |
|
|
|||||